Cellular and Molecular Mechanisms of Drug Dependence
The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Abstract
The molecular and cellular actions of three classes of abused drugs—opiates, psychostimulants, and ethanol—are reviewed in the context of behavioral studies of drug dependence. The immediate effects of drugs are compared to those observed after long-term exposure. A neurobiological basis for drug dependence is proposed from the linkage between the cellular and behavioral effects of these drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The emotional dysregulation that is associated with the withdrawal/negative affect stage also involves a between-system neuroadaptation, in which neuro-chemical systems other than those involved in the positive rewarding effects of drugs of abuse are recruited or dysregulated by chronic activation of the reward system.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [68]
In the citing paper
“A key theory that was proposed was called opponent process theory (Solomon andCorbit, 1973, 1974;D'Amato, 1974;Hoffman and Solomon, 1974;Solomon, 1980;Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“A conceptual framework that was adopted to explain the neural systems that mediate the long-hypothesized opponent process adaptation to excessive reward system engagement and drive negative reinforcement involved the within-system downregulation of brain reward circuitry and the between-system recruitment of brain stress circuitry (Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“Subsequently, the focus of between-system neuroadaptations fell on understanding neurocircuitry within the extended amygdala and its role in opponent process, more specifically hyperkatifeia (Koob and Bloom, 1988;Koob and Le Moal, 2008;Koob, 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“In addition to the above within-system neuroadaptations, other neurocircuits appear to be activated by excessive drug intake that act in hedonic opposition to reward neurotransmitter circuits [corticotropinreleasing factor (CRF), norepinephrine, glucocorticoids, dynorphin, hypocretin, and neuroimmune factors] or act to protect against the development of hyperkatifeia (NPY, nociceptin, endocannabin”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Positron emission tomographic studies of the cortical anatomy of single-word processing
Petersen, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1988) · Nature · doi:10.1038/331585a0 · Cited by 2,593
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Self-citationNucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Self-citationLocalization of Cognitive Operations in the Human Brain
Posner, M. I., Petersen, S. E., Fox, P. T., & Raichle, M. E. (1988) · Science · doi:10.1126/science.3289116 · Cited by 1,429
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00887.1981 · Cited by 1,068
Self-citation
Research works printed but not linked: 46
- AMERICAN JOURNAL OF PSYCHIATRY 142 7: 9 (1985).
- AMIT, Z, ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 23: 65 (1977).
- BAXTER, L. R., JOURNAL OF CLINICAL PSYCHIATRY 49: 23 (1988).
- Bjorklund, A., Handbook of Chemical Neuroanatomy 2: 55 (1984).
- Bloom, F. E., Catecholamines, Neuropharmacology, and Central Nervous System: 159 (1984).
- BRITTON, K.T., REGUL PEPT 16: 315 (1987).
- DACKIS, C.A., BROMOCRIPTINE AS TREATMENT OF COCAINE ABUSE, LANCET 1: 1151 (1985).
- DUGGAN, A. W., PHARMACOLOGICAL REVIEWS 35: 219 (1982).
- EDDY, N.B., BULLETIN OF THE WORLD HEALTH ORGANIZATION 32: 723 (1965).
- FREDERICKSON, RCA, LIFE SCI 24: 541 (1975).
- GRIFFITHS, R.R., ADV SUBSTANC ABUSE 1: 1 (1980).
- HARDING, W.M., ADV SUBSTANC ABUSE 3: 27 (1983).
- HENRIKSEN, S.J., NATL I DRUG ABUSE RE 84: 239 (1984).
- HIMMELSBACH, C.K., FEDERATION PROCEEDINGS 2: 201 (1943).
- HUBNER, C.B., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 1717 (1987).
- JAFFE, J.H., GOODMAN GILMANS PHAR: 532 (1985).
- JAFFE, J.H., RESEARCH PUBLICATIONS. ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE 46: 226 (1968).
- Khachaturian, H., Handbook of Chemical Neuroanatomy 4: 216 (1985).
- KOOB, G.F., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 918 (1987).
- KORNETSKY, C, AN ANIMAL-MODEL FOR OPIATE INDUCED EUPHORIA AND ANALGESIA, THERAPEUTISCHE UMSCHAU 39: 617 (1982).
- KRITIKOS, P.G., UN B NARC 19: 187 (1967).
- Kuhar, M. H., Nature 245:447 (1976).
- LACEY, M.G., INT NARCOTICS RES C: 85 (1988).
- LESLIE, F.M., PHARMACOL REV 39: 198 (1987).
- LI, T.K., NIDA RES MONOGR 66: 41 (1986).
- MADAMBA, S, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 501 (1987).
- Markou A. Soc. Neurosci. Abstr. in press.
- MARTIN, W.R., HDB EXPT PHARMACOLOG 45: 43 (1977).
- MARTIN, W.R., PHARMACOL REV 35: 283 (1984).
- MARTIN, W.R., PHARMACOL REV 35: 285 (1984).
- Merchenthaler, I., Handbook of Chemical Neuroanatomy 3: 273 (1985).
- MURPHY, J.M., ALCOHOL DRUG RES 7: 33 (1986).
- NADEL, L, ESSAYS NERVOUS SYSTE: 367 (1974).
- OBRIEN, C.P., ANN NY ACAD SCI 398: 377 (1983).
- OBRIEN, C.P., PHARMACOL REV 27: 533 (1976).
- PICKENS, R, HDB PSYCHOPHARMACOLO 12: 1 (1978).
- SAMSON, H.H., NEUROBEHAVIORAL PHAR: 221 (1987).
- SHUSTER, L, NIDA RES MONOGR 54: 50 (1984).
- TABAKOFF, B, ANIMAL MODELS ALCOHO: 271 (1980).
- VACCARINO, F.J., EFFECTS OF INTRACEREBROVENTRICULAR ADMINISTRATION OF METHYL NALOXONIUM CHLORIDE ON HEROIN SELF-ADMINISTRATION IN THE RAT, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 23: 495 (1985).
- WALMSLEY, J, PHARMACOL REV 35: 69 (1983).
- WAY, E.L., ANN NY ACAD SCI 398: 12 (1983).
- WHITE, F.J., NEUROPHARMACOLOGY DO: 67 (1987).
- WIKLER, A, NARCOTICS: 85 (1965).
- WILSON, JVR, BEHAV GENET 11: 291 (1984).
- WOODS, J.H., RECENT ADV STUDIES A: 413 (1970).
Cited by
Items 301–400 of 1,010
Edgar, D. M., & Seidel, W. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37050-8 · Cited by 168
Shaham, Y., & Stewart, J. (1994) · Psychopharmacology · doi:10.1007/bf02249346 · Cited by 169
Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C.-E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36769-2 · Cited by 167
Pandey, S. C., Roy, A., & Zhang, H. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000056616.81971.49 · Cited by 168
Dahchour, A., De Witte, P., Bolo, N., Nédélec, J.-F., Muzet, M., Durbin, P., & Macher, J.-P. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00016-x · Cited by 165
Addiction as a coping response: hyperkatifeia, deaths of despair, and COVID-19
Koob, G. F., Powell, P., & White, A. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20091375 · Cited by 166
Self-citationANDERSON, N. B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09595.x · Cited by 165
Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status
Compton, M. A. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90203-8 · Cited by 165
IMPLICATIONS OF ENDOGENOUS OPIOIDS AND DOPAMINE IN ALCOHOLISM: HUMAN AND BASIC SCIENCE STUDIES
GIANOULAKIS, C. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008216 · Cited by 165
Bradberry, C. W., Nobiletti, J. B., Elsworth, J. D., Murphy, B., Jatlow, P., & Roth, R. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03305.x · Cited by 165
Victimization and Substance Abuse among Women: Contributing Factors, Interventions, and Implications
Logan, T., Walker, R., Cole, J., & Leukefeld, C. G. (2002) · Review of General Psychology · doi:10.1037//1089-2680.6.4.325 · Cited by 164
How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?
McKee, S. A., & Weinberger, A. H. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 163
Dynamics of the dopaminergic system as a key component to the understanding of depression
YADID, G., & FRIEDMAN, A. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 162
Cocaine Activation Discriminates Dopaminergic Projections by Temporal Response: An fMRI Study in Rat
Marota, J. J. A., Mandeville, J. B., Weisskoff, R. M., Moskowitz, M. A., Rosen, B. R., & Kosofsky, B. E. (2000) · NeuroImage · doi:10.1006/nimg.1999.0520 · Cited by 163
A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids
Cameron, D. L., Wessendorf, M. W., & Williams, J. T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00444-7 · Cited by 162
An overview of alcohol and tobacco/nicotine interactions in the human laboratory
Verplaetse, T. L., & McKee, S. A. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1189927 · Cited by 160
Guitart, X., Beitner‐Johnson, D., Marby, D. W., Kosten, T. A., & Nestler, E. J. (1992) · Synapse · doi:10.1002/syn.890120310 · Cited by 162
Chapter 19 Dopamine, cognitive control, and schizophrenia: the gating model
Braver, T. S., & Cohen, J. D. (1999) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63082-4 · Cited by 159
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities
Segal, D. M., Moraes, C. T., & Mash, D. C. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00025-9 · Cited by 161
Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence
Allison, C., & Pratt, J. A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00029-9 · Cited by 160
The dark side of opioids in pain management: basic science explains clinical observation
Rivat, C., & Ballantyne, J. (2016) · PAIN Reports · doi:10.1097/pr9.0000000000000570 · Cited by 160
Sufka, K. J. (1994) · Pain · doi:10.1016/0304-3959(94)90130-9 · Cited by 159
Neurochemical changes in cocaine withdrawal
Kuhar, M. J., & Pilotte, N. S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10024-9 · Cited by 159
Perspectives for the development of animal models of bipolar disorder
Machado-Vieira, R., Kapczinski, F., & Soares, J. C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.015 · Cited by 158
The neurobiology of methamphetamine induced psychosis
Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00537 · Cited by 179
Addiction Becomes a Brain Disease
Wise, R. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81134-4 · Cited by 158
Edwards, S., Vendruscolo, L. F., Schlosburg, J. E., Misra, K. K., Wee, S., Park, P. E., Schulteis, G., & Koob, G. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.006 · Cited by 158
Self-citationNetwork Synchrony in the Nucleus Accumbens In Vivo
Goto, Y., & O'Donnell, P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04498.2001 · Cited by 158
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
“In a within-system opponent neuroadaptation, “the primary cellular response element to the drug would itself adapt to neutralize the drug’s effects; persistence of the opposing effects after the drug disappears would produce the withdrawal response” [15].”
BackgroundInfluentialSelf-citationOrbital and Medial Prefrontal Cortex and Psychostimulant Abuse: Studies in Animal Models
Porrino, L. J. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.326 · Cited by 155
Substance Use Disorders in the U.S. Armed Forces
(2013) · National Academies Press eBooks · doi:10.17226/13441 · Cited by 155
Ikemoto, S., Kohl, R. R., & McBride, W. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010137.x · Cited by 155
Innis, R. B., Malison, R. T., Al‐Tikriti, M., Hoffer, P. B., Sybirska, E. H., Seibyl, J. P., Zoghbi, S. S., Baldwin, R. M., Laruelle, M., Smith, E. O., et al. (1992) · Synapse · doi:10.1002/syn.890100302 · Cited by 155
Destruction of the locus coeruleus decreases physical signs of opiate withdrawal
Maldonado, R. J., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91364-x · Cited by 155
Self-citationMalison, R. T., Best, S. E., van Dyck, C. H., McCance, E. F., Wallace, E. A., Laruelle, M., Baldwin, R. M., Seibyl, J. P., Price, L. H., Kosten, T. R., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.832 · Cited by 154
Escalation of drug self-administration as a hallmark of persistent addiction liability
Edwards, S., & Koob, G. F. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283644d15 · Cited by 154
Self-citationCorrigall, W., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000) · Psychopharmacology · doi:10.1007/s002139900355 · Cited by 171
Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models
Eissenberg, T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00735.x · Cited by 152
Resolving the contradictions of addiction
Heyman, G. M. (1996) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00042990 · Cited by 152
Neural responses to acute cocaine administration in the human brain detected by fMRI
Kufahl, P. R., Li, Z., Risinger, R. C., Rainey, C. J., Wu, G., Bloom, A. S., & Li, S.-J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.039 · Cited by 151
Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone
Mallik, A., Chanda, M. L., & Levitin, D. J. (2017) · Scientific Reports · doi:10.1038/srep41952 · Cited by 151
Mark, G. P., Rada, P., Pothos, E., & Hoebel, B. G. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10973.x · Cited by 151
Neurochemical Correlates of Cocaine and Ethanol Self‐Administrationa
Weiss, F., Hurd, Y. L., Ungerstedt, U., Markou, A., Plotsky, P. M., & Koob, G. F. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25970.x · Cited by 160
Self-citationSerotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens
Campbell, A. D., & McBride, W. J. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00050-7 · Cited by 170
Garcia, B., Wei, Y., Morón, J. A., Lin, R., Javitch, J., & Galli, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009092 · Cited by 165
Kong, H., Raynor, K., Yasuda, K., Moe, S. T., Portoghese, P. S., Bell, G. I., & Reisine, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49424-6 · Cited by 148
Friedman, A., Lax, E., Dikshtein, Y., Abraham, L., Flaumenhaft, Y., Sudai, E., Ben-Tzion, M., Ami-Ad, L., Yaka, R., & Yadid, G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.06.008 · Cited by 146
Spies, C. D., Dubisz, N. R., Neumann, T., Blum, S., Muller, C., Rommelspacher, H., Brummer, G., Specht, M., Sanft, C., Hannemann, L., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00009 · Cited by 148
Russell, V. A., de Villiers, A. S., Sagvolden, T., Lamm, M. C. L., & Taljaard, J. J. F. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00177-0 · Cited by 163
Nylander, I., Hyytiä, P., Forsander, O., & Terenius, L. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00118.x · Cited by 147
Carson, D. S., Cornish, J. L., Guastella, A. J., Hunt, G. E., & McGregor, I. S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.018 · Cited by 146
Dyr, W., McBride, W. J., Lumeng, L., Li, T., & Murphy, J. M. (1993) · Alcohol · doi:10.1016/0741-8329(93)90037-o · Cited by 156
Bergquist, J., Ściubisz, A., Kaczor, A., & Silberring, J. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00502-7 · Cited by 160
Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures
Mash, D. C., Kovera, C. A., Pablo, J. P., Tyndale, R. F., ERVIN, F. D., WILLIAMS, I. C., Singleton, E. G., & MAYOR, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05213.x · Cited by 146
Piazza, P. V., Marinelli, M., Jodogne, C., Deroche‐Gamonet, V., Rougé‐Pont, F., Maccari, S., Moal, M. L., & Simon, H. (1994) · Brain Research · doi:10.1016/s0006-8993(09)90034-8 · Cited by 160
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 247
Zangen, A., & Hyodo, K. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00005 · Cited by 145
Xu, M., Guo, Y. H., Vorhees, C. V., & Zhang, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02258-1 · Cited by 162
Memory processes governing amphetamine-induced psychomotor sensitization
Anagnostaras, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00402-x · Cited by 143
“The behavioral activating effects of AMPH and cocaine appear to be mediated by their actions on mesotelencephalic and related circuitry, especially dopaminergic projections to the striatum originating in the ventral tegmental area (VTA) and substantia nigra, and glutamate projections originating in the neocortex (Wise…”
BackgroundCheer, J. F., Heien, M. L. A. V., Garris, P. A., Carelli, R. M., & Wightman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509607102 · Cited by 143
Kiyatkin, E. A., & Gratton, A. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)90231-3 · Cited by 167
Reinstatement and spontaneous recovery of nicotine seeking in rats
Shaham, Y., Adamson, L. K., Corrigall, W. A., & Grocki, S. (1997) · Psychopharmacology · doi:10.1007/s002130050256 · Cited by 157
Zhu, J., & Reith, M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927877 · Cited by 140
Budygin, E. A., John, C. E., Mateo, Y., & Jones, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0002.2002 · Cited by 142
Deroche‐Gamonet, V., Piazza, P. V., Casolini, P., Moal, M. L., & Simon, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90526-s · Cited by 151
Stewart, J., & Wise, R. A. (1992) · Psychopharmacology · doi:10.1007/bf02245289 · Cited by 158
The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease
Mitchell, R. A., Herrmann, N., & Lanctôt, K. L. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00161.x · Cited by 139
Alvaro, J. D., Tatro, J. B., Quillan, J. M., Fogliano, M., Eisenhard, M., Lerner, M. R., Nestler, E. J., & Duman, R. S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09317-4 · Cited by 140
Johansson, B. A., Lindström, K., & Fredholm, B. B. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90288-7 · Cited by 152
Individual differences in the neuropsychopathology of addiction
George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 138
Self-citationFerraro, L., Antonelli, T., O'Connor, W. T., Tanganelli, S., Rambert, F. A., & Fuxé, K. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00353-3 · Cited by 140
Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat
Deransart, C., Riban, V., Lê, B.-T., Marescaux, C., & Depaulis, A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00266-9 · Cited by 152
Georges, F., Stinus, L., Bloch, B., & Moine, C. L. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00462.x · Cited by 139
Wachtel, S. R., Ortengren, A., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00104-7 · Cited by 138
Neurofunctional domains derived from deep behavioral phenotyping in alcohol use disorder
Kwako, L. E., Schwandt, M. L., Ramchandani, V. A., Diazgranados, N., Koob, G. F., Volkow, N. D., Blanco, C., & Goldman, D. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18030357 · Cited by 138
Self-citationRole of oxytocin in the neuroadaptation to drugs of abuse
Sarnyai, Z., & Kovács, G. L. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90062-0 · Cited by 148
Locating Reward Cue at Response Manipulandum (CAM) Induces Symptoms of Drug Abuse
Tomie, A. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00023-2 · Cited by 150
Reduced Thickness of Medial Orbitofrontal Cortex in Smokers
Kühn, S., Schubert, F., & Gallinat, J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.004 · Cited by 147
Ferraro, L., Tanganelli, S., O'Connor, W. T., Antonelli, T., Rambert, F. A., & Fuxé, K. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00182-3 · Cited by 137
Stratford, T. R., Swanson, C. J., & Kelley, A. E. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00140-x · Cited by 147
Where is the locus in opioid withdrawal?
Christie, M. J., Williams, J. T., Osborne, P. B., & Bellchambers, C. E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01045-6 · Cited by 147
Pennartz, C., & Kitai, S. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-09-02838.1991 · Cited by 137
CART in the regulation of appetite and energy homeostasis
Lau, J., & Herzog, H. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00313 · Cited by 136
Svingos, A. L., Chavkin, C., Colago, E. E. O., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.10005 · Cited by 136
Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats.
Lipska, B. K., & Weinberger, D. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8906 · Cited by 134
Bechara, A., & Van der Kooy, D. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.2.351 · Cited by 136
Ramsey, N. F., & van Ree, J. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91461-z · Cited by 143
Nader, K., & van der Kooy, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00383.1997 · Cited by 135
Pulvirenti, L., Swerdlow, N. R., & Koob, G. F. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90095-j · Cited by 146
Self-citationStimulant-induced dopamine increases are markedly blunted in active cocaine abusers
Volkow, N. D., Tomasi, D., Wang, G.-J., Logan, J., Alexoff, D. L., Jayne, M., Fowler, J. S., Wong, C., Yin, P., & Du, C. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.58 · Cited by 134
Adolescent brain maturation and smoking: What we know and where we’re headed
Lydon, D. M., Wilson, S. J., Child, A., & Geier, C. F. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.003 · Cited by 136
Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux
Binda, F., Dipace, C., Bowton, E., Robertson, S. D., Lute, B. J., Fog, J. U., Zhang, M., Sen, N., Colbran, R. J., Gnegy, M. E., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048447 · Cited by 135
Hwang, B. H., Zhang, J.-K., Ehlers, C. L., Lumeng, L., & Li, T.-K. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199906000-00009 · Cited by 134
Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice
McGlacken, G., Jensen, R. A., Meliska, C. J., & Bartke, A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00354-8 · Cited by 148
ERK regulation in chronic ethanol exposure and withdrawal
Sanna, P. P., Simpson, C., Lütjens, R., & Koob, G. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03191-8 · Cited by 142
Self-citationRegulation of NMDA receptors by ethanol
Kumari, M., & Ticku, M. K. (2000) · Progress in Drug Research · doi:10.1007/978-3-0348-8391-7_5 · Cited by 136
Marinelli, M., Piazza, P., Deroche, V, Maccari, S., Le Moal, M., & Simon, H. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02724.1994 · Cited by 133
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine
Gaskill, P. J., Calderon, T. M., Luers, A. J., Eugenin, E. A., Javitch, J. A., & Berman, J. W. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081067 · Cited by 139
Firing patterns of nucleus accumbens neurons during cocaine self-administration in rats
Carelli, R. M., King, V. C., Hampson, R. E., & Deadwyler, S. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90557-4 · Cited by 135
Ghitza, U. E., Fabbricatore, A. T., Prokopenko, V., Pawlak, A. P., & West, M. O. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07239.2003 · Cited by 133
Metadata
- Authors
- Koob, G. F., & Bloom, F. E.
- Affiliations
- Scripps Clinic (US)
- ORCID
- Koob, George F.
- Venue
- Science
- Published
- 1988-11-04
- Volume
- 242
- Issue
- 4879
- Pages
- 715-723
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061161259
- Semantic Scholar
- f6c96457aa8e089ddd837d35937c60d29361c45f
- Cited by
- 2,070
- References
- 189
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 15 · 2023: 19 · 2022: 24 · 2021: 25 · 2020: 30 · 2019: 40 · 2018: 32 · 2017: 24 · 2016: 35 · 2015: 39 · 2014: 47 · 2013: 51 · 2012: 56
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-06420)
- National Institute on Drug Abuse (DA04043, DA04398)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug addiction, opiates, psychostimulants, ethanol, neurobiology of addiction, drug effects on behavior, long-term drug exposure
- MeSH terms
- Ethanol, Animals, Behavior, Animal, Brain, Cocaine, Drug Tolerance, Humans, Opium, Reinforcement, Psychology, Neurotransmitter Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.